chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pain at the injection site; headache; joint pain; fatigue; chills; This is a spontaneous report from a contactable Pharmacist. A female patient of an unspecified age received BNT162B2 via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient shared information about her experience after receiving the Pfizer BioNTech COVID-19 vaccine. The patient reported pain at the injection site, headache that she treated with Naproxen, joint pain, fatigue, and chills that lasted for 72 hours. Events outcome was unknown.  Information on the Batch/Lot number has been requested.
At 17:00, pt had temperature of 101F and reached 105.9F at 08:00 today. Pt was taken to ER. Pt was discharged 3 hours later. At 14:00, the pt's temperature was 100F. Mother had given pt ibuprofen 200mg every 4 hours without any effect on her temperature. On 7/19/01, the pt's temperature was 100F.
feeling itchy; redness to left deltoid of injection site which then spread to left shoulder and across chest; Initial information received on 18-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer (office staff).  This case involves an unknown age female patient who experienced feeling itchy (pruritus) and redness to left deltoid of injection site which then spread to left shoulder and across chest (erythema), while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot UJ209AA via unknown route in the left arm.  On an unknown date, the patient experienced a non-serious feeling itchy (pruritus) and redness to left deltoid of injection site which then spread to left shoulder and across chest (erythema) (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  Patient remained in clinic for 15 minutes after injection of DECADRON.  (Other relevant tests included no lab data.)  Final diagnosis was redness to left deltoid of injection site which then spread to left shoulder and across chest and feeling itchy.   The patient was treated with 150 mg twice daily RANITIDINE HYDROCHLORIDE (ZANTAC) and 8 mg DEXAMETHASONE ACETATE (DECADRON A) to left dorogluteal.  The patient outcome was not reported for redness to left deltoid of injection site which then spread to left shoulder and across chest and feeling itchy.  List of documents held by sender: none.
experienced six months of joint pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): 2022NVX-US-000004151.  A male patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single, Pfizer BioNTech COVID-19 Vaccine (tozinameran), Lot number: unknown), for COVID-19 immunisation.  The following information was reported: ARTHRALGIA (non-serious), outcome "recovered", described as "experienced six months of joint pain".  Additional information: On 07Nov2022, it was reported that a patient started treatment on an unspecified date with Pfizer BioNTech COVID-19 Vaccine (tozinameran) dose 1, dose 2, and a booster dose for COVID-19 immunisation. It was reported the patient experienced six months of joint pain after the second dose. He experienced adverse reactions again after the Pfizer booster dose. He had joint pains, sickness and it reportedly lasted for a long time. At the time of reporting, the patient still had those joint pains.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
After I had the 2nd dose of the Pfizer, my left arm was numb and couldn?t drive but I was able to live with it until the 4th day, during working period I suddenly felt dizzy and nauseous, went to throw up, dizziness was intense then I fell off my chair and was rushed to the Emergency for treatment, was treated for vertigo and given Meclizine to reduce the dizziness and nausea. Till date the dizziness wouldn?t go away.
severe headache; chills; low-grade fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (severe headache), CHILLS (chills) and PYREXIA (low-grade fever) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 031B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-May-2021, the patient experienced HEADACHE (severe headache), CHILLS (chills) and PYREXIA (low-grade fever). At the time of the report, HEADACHE (severe headache), CHILLS (chills) and PYREXIA (low-grade fever) outcome was unknown.          No concomitant medications provided. No treatment information provided.
On March  14 I have papule over the forehead which became scaly and red  at the same time I have left parotid  painful  parotid. and enlarged all the lymph nodes around  Pain was mild and  everything resolved. In 4 days except for the skin. Lesions which is improving but slowly
Patient stated that she became hoarse and could barely talk. Dr confirmed she had left vocal chord paralysis.
Patient reported to the emergency room with legs feeling heavy, numb, and tingling with body aches
Within 2 hrs after vaccine - pain in injection site and arm is swollen. No heat. States pain goes up neck on (L) side. Also runs down to (L) arm.
Mother states child developed Rash 48 hrs. after receiving vaccine. She carried child to Dr. for evaluation. Mother states Dr. told her it was not chicken pox. Mother gave child BENADRYL 1x. Brought child into Health Dept. 4-17-17 for Nurse to see child. Child has red cheeks with Lace-Like pattern rash over body from neck down. Mother states rash started on face and spread down body.
At approximately hour 40 post vaccine my Axillary lymph node became very enlarged, painful and hard.  It was causing a tingling in my arm, like a pinched nerve and was painful to keep my arm in a relaxed position.  The node was visible if I lifted my arm above my head.  With a dose of ibuprofen, the swelling reduced but it was still palpable and painful for the next 18 hours.  By the 72 hour vaccine mark, all symptoms were gone.
This spontaneous report was received from a nurse practitioner and refers to a 30-year-old patient of unknown gender. No information about patient's medical history, concurrent conditions, concomitant medications, drug reactions or allergies was provided. On unknown dates (reported as "on unspecified dates in the past"), the patient was vaccinated with an unspecified number of doses of M-M-R II (strength, dose, route of administration, lot# and expiration date were not reported). On an unknown date, the patient had low titers for M-M-R. The outcome of low titers for M-M-R was unknown. The relatedness between M-M-R II and the event was not reported. Additional information has been requested.
This case was reported by a consumer and described the occurrence of injection site pain in a male patient who received SHINGRIX. On 20th April 2018, the patient received SHINGRIX. On 20th April 2018, less than a week after receiving SHINGRIX, the patient experienced injection site pain, swelling and rash. The patient was treated with Probiotics. On an unknown date, the outcome of the injection site pain, swelling and rash were unknown. It was unknown if the reporter considered the injection site pain, swelling and rash to be related to SHINGRIX. Additional information were provided as follows: The patient was provided with information about possible rash but no photo of how the rash would looked like. As anticipated, the patient had pain in arm and swelling along with a developing rash. The course of antibiotics started along with a course of probiotic. This case was linked with US2018GSK076229, reported by the same reporter.
This spontaneous report as received from a 64 years old male patient with herpes simplex and no drug reactions/allergies. The patient was vaccinated with a dose of ZOSTAVAX on 24-DEC-2012. Concomitant medications included: LIPITOR. On approximately 24-DEC-2012 (within 24-48 hours), the patient experienced worsening of his herpes simplex symptoms after receiving ZOSTAVAX. He stated that he had never had shingles, and his healthcare professional (HCP) did not think there was a correlation with the worsening rash and vaccination. The patient went to HCP for medical attention. He was treated with VALTREX and cream. Blood test was performed. The outcome of worsening of his herpes simplex symptoms was unknown. Additional information is not expected.
A report has been received from a Pharmacist concerning an Adult, female subject, who had been receiving nasal FLUMIST Quadrivalent. FLUMIST Quadrivalent started on an unknown date. The reporter stated that the patient experienced expired FLUMIST Quadrivalent administered which started on 09-DEC-2014. The expiry date was reported as 24-NOV-2014. The outcome of the event of expired FLUMIST Quadrivalent is unknown. the report was considered to be non-serious.
This spontaneous report as received from a health care worker refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 20-AUG-2015 the patient was vaccinated with improperly stored VARIVAX (Merck) (lot # L006386, expiration date 25-FEB-2017, 0.5 ml, subcutaneous). No adverse effects reported. This is one of two reports received from the same source. Additional information has been requested.
Child had Vaccine given in the right arm at a flu vaccine clinic at the School. Approximately 10 minutes after getting vaccine mother called the school nurse stating child had been vomiting and crying since injection and her arm was red in color. School RN instructed the mom to take the child to a local urgent care or ER. Mother took child after giving benedryl at home and let school nurse that child had become better once at the ER.
Patient contacted pharmacy at 1:06 pm on April 28th after she left the pharmacy at 12:40 pm (patient was monitored for 15 minutes after receiving vaccination) .  Patient stated she had headache before she came to the pharmacy.  When she contacted us at 1:06pm, she stated her headache was improved, forehead felt numb, upper lips felt numb.  I suggested her to take Benadryl 50 mg and monitored sign/symptoms of allergic reaction, and have someone accompany her and call 911 if needed.  We followed up with patient by phone around 1:32 pm. Patient stated she was in front of  hospital and waited to see if any other serious symptoms appear.  We advised her again to go to ER if symptoms worsen.
An hour after I received the vaccine, I became light-headed and started feeling tingling in my upper body. My lips were tingling and became numb. My throat also started to feel tight. I did receive Benadryl IVP 25mg within 5 minutes of reaction.
SEVERE CHILLS, FATIGUE, PAIN AND SWELLING IN ARM.  RASH ON SHOULDER/ARM.  FATIGUE LASTED 3 DAYS.  FEVER LASTED 2 DAYS.
Fatigue; Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) and PAIN IN EXTREMITY (Pain in arm) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Plaque psoriasis.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA)  (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced FATIGUE (Fatigue) and PAIN IN EXTREMITY (Pain in arm). At the time of the report, FATIGUE (Fatigue) and PAIN IN EXTREMITY (Pain in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment medication information was not provided by the reporter. This case was identified as part of a retrospective clean-up activity where certain emails received in the moderna mailbox were missed to be booked-in.
Mom brought babe into clinic for checkup with NP. Discussed about occurrences, mom states client became"ill" week of 9/11/05 with "cough, headache, tummy ache, petechiae around eyes." Had seizure on 9/20/05 and took her to ER. "She had URI, ear infection" MD ordered ABX, on 9/21/05, she started ABX. Mom reports another seizure on 9/22/05 and returned to ER. Had EEG with F/U CT scan. Showed "spikes on right side of brain from infection". Plas of F/U EEG on 10/21/05 per doctor and other doctor. Mom states MD in ER took meds sulfa, PCN off allergy record "not real allergies'. Mom discovered rash on sister 3 days after seizures- "it was roseola." Client had appt with NP today for continued "cough." Mom states client has had only one febrile seizure.
No other AE and no PQC; expired dose of GARDASIL 9 to a patient on 10/19/2023; This spontaneous report has been received from a nurse, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent condition and concomitant medication was not provided.  On 19-OCT-2023, the patient was vaccinated with an expired dose (1 dosage form) of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (formulation Prefilled syringe, lot # U008899 with expiration date: 12-AUG-2023, strength and route were unknown) for prophylaxis (expired product administered). Operator of device was health professional. The reporter confirmed no previous temperature excursions for the suspect product and stored in the recommended range. There are no symptoms or further details to report. The reporter requested if the administration period was supported beyond the labeled expiry. No other adverse event and no product quality complaints.
Persistent headache from the time of administration. Swelled ganglia in left axilla and pain in the area with limitation of movement.
Information has been received from a registered nurse concerning a 33 year old female who in 1990 was vaccinated with a dose of MMR. It was also reported that in 1972, the patient received rubella vaccination. A current (approximately November 2004) titer shows low antibodies to rubella. Unspecified medical attention was sought. No product quality complaint was involved. No other information is available. No further information is expected.
dizziness/dizzy spells; it is like a vasovagal response; This is a spontaneous case is received from a contactable consumer or other non hcp. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration (Batch/Lot number was not reported) as SINGLE DOSE on 08Mar2021 for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported.  On 10Apr2021 the patient experienced dizziness/dizzy spells (dizziness) and also reported it is like a vasovagal response (presyncope). The patient reported it is like a vasovagal response that happens 24 hours a day, 7 days a week. The patient was upset when informed that dizziness was not reported in the clinical trials as a side effect of the vaccine. Caller states he regrets taking the vaccine. "I am going to proceed legal action against you." "See you in court". The outcome of the events was unknown.  Follow-up (12Apr2021): New information received from the same contactable consumer (patient).  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Admitted to Hospital on Date of Adverse Event  for treatment of Covid-19 Positive following completion of Covid Vaccine Series
Disorientation; Dizziness; Chills; Fever; Joint aches; Severe headache; Loss of appetite; Nausea; Inability to articulate words and phrases; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the arm left on 23Apr2021 at 12:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 02Apr2021 at 12:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. On 24Apr2021 at 12:00, the patient experienced disorientation, dizziness, chills, fever, joint aches, severe headache, loss of appetite, nausea and inability to articulate words and phrases. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events disorientation, dizziness, chills, fever, joint ache, headache, appetite lost, nausea and thinking slow was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Symptoms began 10 minutes after vaccine administration as tingling in the tongue and progressed to swelling of the toungue
Joint pain, muscle pain, 104 temp, fatigue, headache, weakness and heart palpitations
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE REVERSIBLE ISCHEMIC NEUROLOGIC DEFICIT SYNDROME HYPOTENSION  11/15/2022  --  RECURRENCE OF SAME SYMPTOMS
This is one of three consecutive pt to devel a fever of 103 deg. F and a rash after receipt of tetramune w/ this lot.
got the shot it didn't work/ suspected vaccination failure; got the shot it didn't work; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The reporter stated that, got the shot but it did not work. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for shingles were not provided.
Some numbness in the left arm at the injection site; Felt sluggish; Slowness in the body; Chills; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE HYPOAESTHESIA (Some numbness in the left arm at the injection site), SLUGGISHNESS (Felt sluggish), BRADYKINESIA (Slowness in the body) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE HYPOAESTHESIA (Some numbness in the left arm at the injection site), SLUGGISHNESS (Felt sluggish), BRADYKINESIA (Slowness in the body) and CHILLS (Chills). At the time of the report, INJECTION SITE HYPOAESTHESIA (Some numbness in the left arm at the injection site), SLUGGISHNESS (Felt sluggish), BRADYKINESIA (Slowness in the body) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
No additional adverse events reported.; Nurse called to report a child received a dose of expired PROQUAD.; This spontaneous report was received from a registered nurse, referring to a child patient of unknown gender. The patient's pertinent medical history, current conditions, previous drug reactions or allergies were not reported.   On 23-OCT-2020, the patient received an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD), at a dose of 0.5 milliliter (ml), for prophylaxis (formulation, strength, vaccination scheme and anatomical site of vaccination were not reported, lot number S012532, which has been verified to be valid, expiration date reported and validated as 20-OCT-2020) (expired product administered). As concomitant therapy, a sterile diluent (MERCK STERILE DILUENT) (lot number and expiration date were reported as unknown) was used to reconstitute the vaccine. No additional adverse events were reported.
Pain and numbness in arm.  Began when shot was given and is continuing.  Has difficulty lifting arm and tingling esp. at night.
A company representative reported that a 2 year old female received Prevnar vaccine and subsequently developed an allergic reaction including hives. She was treated with diphenhydramine (Benadryl) and recovered. The reporter noted that the pt was allergic to penicillin and cephalosporins. Follow up infomation was received from the physician on 03/05/2001 which identified the patient, date of vaccination and adverse event onset.
2 days after receiving the 1st vaccine,  I started getting night sweats and mild fever. Then a day later, I started getting an itch in my throat followed by a deep cough. I had to order Azithromycin and Prednisone to kill whatever what was going on.  I was sick for 3 full weeks.   Alternatively,  my 76 father   passed away only hours after receiving his 2nd moderna vaccine. We share the same number and I have to enter his information also.
Extreme fatigue, fever of 101.2, severe chills/shakes, muscle aches
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 78-year-old male patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX (1st dose, refer linked case US2018165509). On 11th September 2018, the patient received the 2nd dose of SHINGRIX. On 11th September 2018, less than a day after receiving SHINGRIX, the patient experienced pain in arm. Rechallenge with SHINGRIX was positive. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional information was reported as follows: The case was reported by the patient's wife. On the date of reporting after vaccination with SHINGRIX, the patient experienced arm soreness. The reporter stated that till the time of reporting the patient had experienced only arm soreness as an event.
DTaP, HIB, IPV given at WCE 8/12/13 at 1:30 pm. At 5 pm mom noticed 2" red, firm wheal at site on LT. No other s/s. Called this am, wheal decreased to 1", continues to feel well 8/14/13 redness resolved.
PAtient had second Covid vaccine one day prior and presented to urgent care complaining of rash, easy bruising